$ILMN

Meister Keith A. sold $2.6M of ILMN (indirect holdings)

Meister Keith A. sold 15,472 indirectly-held shares of ILLUMINA, INC. (ILMN) at $165.50 ($2.56M total) on 2026-06-01.

Original reporting
SEC EDGAR · Meister Keith A.
Published Jun 1, 2026, 10:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ILMN
Neutral
medium confidence
Mentioned
$ILMN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but does not, by itself, change Illumina’s operating outlook.

02

Market read

Traders may monitor for additional insider activity or corroborating fundamental news, but the filing alone is unlikely to drive a major repricing.

03

What to watch

No 10b5-1 plan is indicated in the filing details provided; traders may over-weight intent versus routine portfolio management.

Relevance 6/10Novelty 6/10Timing: Filed today (2026-06-01) for an open-market sale executed on the same date.

Background

This is an SEC Form 4 insider transaction disclosure for Illumina, Inc. (ILMN).

Company-level read

Ticker impact

$ILMNNeutralMedium confidence
Context

Illumina director Keith A. Meister sold 15,472 shares in an open-market transaction worth about $2.56M, disclosed via SEC Form 4.

Expected impact

Low likelihood of sustained price impact; any effect is likely short-lived unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is an insider transaction (Form 4) with no 10b5-1 plan cited and no accompanying company-specific catalyst (earnings, guidance, deal).

Market effects

Limited read-through to biotech/genomics tools; this is company-specific insider activity without sector-wide catalyst.

None.

None.

Counterpoint

A director sale can reflect diversification or pre-planned liquidity needs rather than negative expectations, especially when not tied to a new fundamental event.

Key entities

  • Illumina, Inc.

    Subject of the SEC Form 4 insider sale by a director.

  • Keith A. Meister

    Director who sold 15,472 shares on 2026-06-01.

Related articles

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Illumina (ILMN) reported Q2 2026 revenue of $1.16B, up 9.5% YoY, and non-GAAP EPS of $1.31. Clinical consumables and NovaSeq X placements drove results. Gross margin was 68.2%. Full-year 2026 guidance was raised to $4.60B-$4.64B revenue and $5.30-$5.40 EPS. Cash was $1.17B vs $1.99B debt.

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer - Jacob Thaysen Chief Financial Officer - Ankur Dhingra TAKEAWAYS Total Revenue -- $1.16 billion, representing a 9.5% increase year over year driven by clinical market demand and the NovaSeq X expansion. Rest of World Organic Revenue -- Increased 8.1% year over year, exceeding the high end of management's previous guidance.

$ILMNMedAI 8/10

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full

Genomics company Illumina (NASDAQ: ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.62 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 6.8% above analysts’ consensus estimates. Is now the time to buy Illumina? Find out by accessing our full research report, it’s free.

$ILMNHigh

ILLUMINA, INC. (ILMN): Results of Operations and Financial Condition

ILLUMINA, INC. (ILMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsrelease.htm EX-99.1 Document Investors: Conor McNamara +1.858.291.6421 ir@illumina.com Media: Christine Douglass pr@illumina.com Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 San Diego, July 30, 2026 /PRNewswire/ -- Illumina, Inc.